Nutex Health Inc. (NUTX)
NASDAQ: NUTX · Real-Time Price · USD
174.71
+0.95 (0.55%)
At close: May 16, 2025, 4:00 PM
166.00
-8.71 (-4.99%)
After-hours: May 16, 2025, 7:59 PM EDT
Nutex Health Stock Forecast
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for Nutex Health stock ranges from a low of $100 to a high of $300. The average analyst price target of $200 forecasts a 14.48% increase in the stock price over the next year.
Price Target: $200.00 (+14.48%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Nutex Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Strong Buy Maintains $150 → $300 | Strong Buy | Maintains | $150 → $300 | +71.71% | May 15, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $75 → $100 | Strong Buy | Maintains | $75 → $100 | -42.76% | Apr 8, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $50 → $75 | Strong Buy | Maintains | $50 → $75 | -57.07% | Feb 13, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $45 → $50 | Strong Buy | Maintains | $45 → $50 | -71.38% | Nov 12, 2024 |
| Benchmark | Benchmark | Strong Buy Maintains $45 → $60 | Strong Buy | Maintains | $45 → $60 | -65.66% | Nov 12, 2024 |
Financial Forecast
Revenue This Year
473.85M
from 479.95M
Decreased by -1.27%
Revenue Next Year
508.52M
from 473.85M
Increased by 7.32%
EPS This Year
4.15
from 9.71
Decreased by -57.28%
EPS Next Year
4.55
from 4.15
Increased by 9.67%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 575.5M | 596.0M |
| Avg | 473.9M | 508.5M |
| Low | 330.4M | 363.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 19.9% | 25.8% |
| Avg | -1.3% | 7.3% |
| Low | -31.2% | -23.3% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | 11.13 | 8.42 |
| Avg | 4.15 | 4.55 |
| Low | 0.25 | 0.88 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | 14.6% | 103.0% |
| Avg | -57.3% | 9.7% |
| Low | -97.5% | -78.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.